Androgen receptor cistrome in breast cancer cell line MDA-MB-453 with 5a-dihydrotestosterone (DHT) stimulation
Source: NCBI BioProject (ID PRJNA143095)
Source: NCBI BioProject (ID PRJNA143095)
0 0
Project name: Homo sapiens
Description: Androgen receptor (AR) is expressed in 60-70% of breast cancers independent of estrogen receptor (ER) expression, however its function in breast cancer is largely unknown. Our study identified the high level of AR in ER/HER2+ breast tumors and andorgen and AR greatly stimulated growth of MDA-MB-453 breast cancer cells. To define the genome-wide AR binding sites, we performed AR ChIP-seq using MDA-MB-453 breast cancer cells followig stimulation of DHT. We also identified FOXA1 is a crucial AR cofactor in MDA-MB-453 cells and the FOXA cistrome showed signaficant overlap with AR at both early and late time points of DHT stimulation.Overall design: AR ChIP was performed in MDA-MB-453 breast cancer cells following 5a-dihydrotestosterone (DHT) stimulation for 4h and 16h respectively. FOXA1 ChIP-seq was performed after 4h DHT stimulation in MDA-MB-453 cells.
Data type: Epigenomics
Sample scope: Multiisolate
Relevance: Medical
Organization: Xiaole Shirley Liu, Biostatistics and Computational Biology, Dana Farber Cancer Institute and Harvard School of Public Health
Literatures
- PMID: 21741601
Release date: 2011-07-11
Last updated: 2011-04-21